Home | Provider Manual Home | Contributors | Technical Information
Preface | Note to Users | Feedback | Disclaimer
search CALS Provider Manual
Collapse All  |  Expand All
  • Volume I:
    First Thirty Minutes
    • Section 1
      Acute Care Algorithm/ Treatment Plans/ Acronyms
      • CALS Approach
        • CALS Universal Approach
        • Patient Transport
      • Airway
        • Rapid Sequence Intubation Algorithm/Rescue Airways
        • Endotracheal Intubation FlowSheet
        • Rapid Sequence Intubation Medications
        • Rapid Sequence Intubation Drug Calculator
        • Rapid Sequence Intubation Dosage Chart
        • Obstructed Airway Algorithm Adult and Pediatric
        • Initial Laboratory Studies
      • Cardiovascular
        • CPR Steps for Adults, Children, and Infants
        • Automated External Defibrillator Algorithm
        • Ventricular Fibrillation-Pulseless Ventricular Tachycardia Algorithm
        • Pulseless Electrical Activity Algorithm-Adult and Peds
        • Asystole Algorithm-Adult and Peds
        • Bradycardia Algorithm
        • Tachycardia Algorithm
        • Atrial Fibrillation/Atrial Flutter Algorithm
        • Electrical Cardioversion Algorithm-Adult and Pediatric
        • Chest Pain Evaluation Algorithm
      • Emergency Preparedness
        • Therapeutic Hypothermia
        • Mobilization Checklist
        • Symptom Recognition-Therapy
        • Blast Injuries
      • Fluids & Electrolytes
        • Causes of Anion and Non-Anion Gap Acidosis
      • Infection
        • Sepsis Guidelines
      • Neonatal
        • Neonatal Resuscitation Algorithm
        • Inverted Triangle-APGAR Score
        • Drugs in Neonatal Resuscitation Algorithm
      • Neurology
        • Altered Level of Consciousness
        • Glasgow Coma Scale-Adult, Peds,Infant
        • Tips From the Vowels Acronym
        • NIH Stroke Scale (Abbreviated)
        • Status Epilepticus Treatment Plan
      • Obstetrics
        • Postpartum Hemorrhage Algorithm
        • Shoulder Dystocia—HELPERR
        • Vacuum Delivery Acronym-ABCDEFGHIJ
      • Ophthalmology
        • Central Retinal Artery Occlusion
        • Chemical Burn Exposure to Eye
      • Pediatrics
        • Pediatric Equipment Sizes
        • Modified Lund Browder Chart
      • Trauma
        • Shock Acronym-Shrimpcan
        • Burn Management Treatment Plan
        • Initial Care of Major Trauma
        • Trauma Flow Sheet
    • Section 2
      Universal Approach
      • CALS Universal Approach To Emergency Advanced Life Support
    • Section 3
      Steps 1-6
      • Steps 1-6
      • Step 1: Activate the Team
      • Step 2: Immediate Control and Immobilization
      • Step 3: Initial Survey
      • Step 3: Simultaneous Team Action By Team Members
      • Step 4: Preliminary Clinical Impression
      • Step 5: Working Diagnosis and Disposition
      • Step 6: Team Process and Review
    • Section 4
      Preliminary Impression/Focused Clinical Pathways
      • Pathway 1: Altered Level of Consciousness (Adult and Pediatric)
      • Pathway 2: Cardiovascular Emergencies (Adult and Pediatric)
      • Pathway 3: Gastrointestinal/Abdominal Emergencies (Adult and Pediatric)
      • Pathway 4: Neonatal Emergencies
      • Pathway 5: Obstetrical Emergencies
      • Pathway 6: Adult Respiratory
      • Pathway 7: Pediatric Respiratory
      • Pathway 8: Adult Trauma (Secondary Survey for Adults)
      • Pathway 9: Pediatric Trauma (Secondary Survey for Trauma in Children)
  • Volume II:
    Resuscitation Procedures
    • Section 5
      Airway Skills
      • Airway Skills 1: Aids to Intubation
      • Airway Skills 2: Bag-Valve-Mask Use
      • Airway Skills 3: Orotracheal Intubation
      • Airway Skills 4: Rapid Sequence Intubation
      • Airway Skills 5: Cricoid Pressure and the BURP Technique
      • Airway Skills 6: Esophageal Tracheal Combitube
      • Airway Skills 7: King Airway
      • Airway Skills 8: Intubating Laryngeal Mask Airway
      • Airway Skills 9: Nasotracheal Intubation
      • Airway Skills 10: Topical Anesthesia
      • Airway Skills 11: Retrograde Intubation
      • Airway Skills 12: Tracheal Foreign Body Removal
      • Airway Skills 13: Cricothyrotomy
      • Airway Skills 14: Tracheotomy
      • Airway Skills 15: Tracheotomy in Infants
      • Airway Skills 16: Transtracheal Needle Ventilation
    • Section 6
      Breathing Skills
      • Section 6 Breathing Skills Portals
      • Breathing Skills 1: Chest Tube Insertion
      • Breathing Skills 2: Chest Suction and Autotransfusion
      • Breathing Skills 3: Endobronchial Tube
      • Breathing Skills 4: Heliox
      • Breathing Skills 5: Needle Thoracostomy
    • Section 7
      Circulation Skills
      • Section 7 Circulation Skills Portals
      • Circulation Skills 1: Arterial and Venous Catheter Insertion
      • Circulation Skills 2: Central Venous Access
      • Circulation Skills 3: Central Venous Pressure Measurement
      • Circulation Skills 4: Emergency Thoracotomy
      • Circulation Skills 5: Intraosseous Needle Placement (Adult)
      • Circulation Skills 6: Pericardiocentesis
      • Circulation Skills 7: Rewarming Techniques
      • Circulation Skills 8: Saphenous Vein Cutdown
      • Circulation Skills 9: Transvenous Cardiac Pacing
    • Section 8
      Disability Skills
      • Section 8 Disability Skills Portals
      • Disability Skills 1: Skull Trephination
      • Disability Skills 2: Raney Scalp Clips
    • Section 9
      Trauma Skills
      • Trauma Skills Portals
      • Trauma Skills 1: Compartment Pressure Measurement
      • Trauma Skills 2: Femur Fracture Splinting
      • Trauma Skills 3: Pelvic Fracture Stabilization
      • Trauma Skills 4: Suprapubic Cystostomy
    • Section 10
      X-Rays Skills
      • X-ray Skills 1: Cervical Spine Rules and Use of Imaging Portal
      • X-ray Skills 2: Cervical Spine X-ray Interpretation
      • Xray Skills 3: Interpretation of a Pelvic X-ray
  • Volume III:
    Definitive Care
    • Section 11
      Airway
      • Rapid Sequence Intubation Portal
      • Airway Obstruction Portal
      • Heliox Treatment Portal
      • Ventilator Management Portal
      • Noninvasive Ventilatory Support Portal
      • Inspiratory Impedance Threshold Device Portal
      • Status Asthmaticus Portal
      • Anaphylaxis Portal
    • Section 12
      Cardiovascular
      • Cardiovascular 1: Classification of Pharmacological (Therapeutic) Interventions Portal
      • Cardiovascular 2: Cardiac Rhythms Portal
      • Cardiovascular 3: Pharmacology of Cardiovascular Agents Portal
      • Cardiovascular 4: Endotracheal Drug Delivery
      • Cardiovascular 5: Ventricular Fibrillation/Pulseless Ventricular Tachycardia Portal
      • Cardiovascular 6: Pulseless Electrical Activity Portal
      • Cardiovascular 7: Asystole Treatment Portal
      • Cardiovascular 8: Tachycardia Treatment Portal
      • Cardiovascular 9: Electrical Cardioversion Portal
      • Cardiovascular 10: Bradycardia Treatment Portal
      • Cardiovascular 11: Acute Coronary Syndromes Portal (Acure Ischemic Chest Pain)
      • Cardiovascular 12: Acute Heart Failure Portal
      • Cardiovascular 13: Hypertensive Crises Portal
      • Cardiovascular 14: Digitalis Toxicity Portal
      • Cardiovascular 15: Long QT Syndrome Portal
      • Cardiovascular Diagnostic Treatment Portals
    • Section 13
      Emergency Preparedness
      • Emergency Preparedness 1: Community-Wide Collaboration Portal
      • Emergency Preparedness 2: Approaches to Planning
      • Emergency Preparedness 3: Hazard Vulnerability Analysis Portal
      • Emergency Preparedness 4: Incident Command System Portal
      • Emergency Preparedness 5: Emergency Management Program Portal
      • Emergency Preparedness 6: Basic All Hazards Response Portal
      • Emergency Preparedness 7: Rapid and Efficient Mobilization Portal
      • Emergency Preparedness 8: Emergency Event Response Classifications Portal
      • Emergency Preparedness 9: Triage Portal
      • Emergency Preparedness 10: Surge Capacity Planning and Scarce Resources Guidelines
      • Emergency Preparedness 11: Glossary of Terms
      • Emergency Preparedness 12: Resources
      • Emergency Preparedness 13: Introduction to Nuclear, Biological, and Chemical Warfare
      • Emergency Preparedness 14: Nuclear Devices Portal
      • Emergency Preparedness 15: Acute Radiation Syndrome Portal
      • Emergency Preparedness 16: Biological Agents Portal
      • Emergency Preparedness 17: Chemical Agents Portal
      • Emergency Preparedness 18: Explosion and Blast Injuries Portal
      • Emergency Preparedness 19: Patient Isolation Precautions
      • Emergency Preparedness 20: Additional References and Resources
    • Section 14
      Endocrine and Metabolic
      • Endocrine and Metabolic 1: Adrenal Crisis Portal
      • Endocrine and Metabolic 2: Diabetic Ketoacidosis Portal
      • Endocrine and Metabolic 3: Myxedma Coma (Severe Hypothyroidism) Portal
      • Endocrine and Metabolic 4: Thyroid Storm Portal (Severe Thyrotoxicosis/Hyperthyroidism)
      • Endocrine and Metabolic 5: Hyperosmolar (Hyperglycemic) Non-Ketotic State Portal
      • Endocrine and Metabolic 6: Acid-Base Portal Concepts and Clinical Considerations
      • Endocrine and Metabolic 7: Disorders of Electrolyte Concentration Portal
    • Section 15
      Environmental
      • Environmental 1: Hypothermia Portal
      • Environmental 2: Hyperthermia/Heat Stroke Portal
      • Environmental 3: Burns Management Portal
      • Environmental 4: Near Drowning Portal
      • Environmental 5: High Altitude Illness Portal
      • Environmental 6: Snake Bite Portal
    • Section 16
      Farming
      • Farming 1: Respiratory Illnesses Portal
      • Farming 2: Farm Wounds/Amputation Portal
      • Farming 3: Chemical Exposures Portal
    • Section 17
      Gastrointestinal/
      Abdominal
      • Gastrointestinal/Abdominal 1: Esophageal Varices Portal
    • Section 18
      Geriatrics
      • Geriatrics 1: General Aging Portal
    • Section 19
      Infection
      • Infection 1: Adult Pneumonia
      • Infection 2: Meningitis Portal
      • Infection 3: Sepsis in Adults Portal
      • Infection 4: Abdominal Sepsis Portal
      • Infection 5: Tetanus Immunization Status Portal
    • Section 20
      Neonatal
      • Neonatal 1: Neonatal Resuscitation Algorithm
      • Neonatal 2: Drugs in Neonatal Resuscitation
      • Neonatal 3: Meconium Suctioning Portal
      • Neonatal 4: Umbilical Artery and Vein Cannulation Portal
      • Neonatal 5: Inverted Triangle/Apgar Score Portal
      • Neonatal 6: Meningitis/Sepsis in Newborn Portal
      • Neonatal 7: Respiratory Distress Syndrome Scoring System Portal
    • Section 21
      Neurology
      • Neurology 1: Status Epilepticus Portal
      • Neurology 2: Stroke Portal
      • Neurology 3: NIH Stroke Scale Portal
      • Neurology 4: Phenytoin and Fosphenytoin Loading Portal
      • Neurology 5: Increased Intracranial Pressure Portal
    • Section 22
      Obstetrics
      • Obstetrics 1: Physiology of Pregnancy Portal
      • Obstetrics 2: Ultrasound Use Portal
      • Obstetrics 3: Bleeding in Early Pregnancy/Miscarriage Portal
      • Obstetrics 4: Dilatation and Curettage Portal
      • Obstetrics 5: Fetal Heart Tone Monitoring Portal
      • Obstetrics 6: Preterm Labor Management Portal
      • Obstetrics 7: Bleeding in the Second Half of Pregnancy Portal
      • Obstetrics 8: Hypertension In Pregnancy Portal
      • Obstetrics 9: Trauma in Pregnancy Portal
      • Obstetrics 10: Emergency Cesarean Section Portal
      • Obstetrics 11: Imminent Delivery Portal
      • Obstetrics 12: Malpresentations and Malpositions: Breech, Occiput Posterior Portal
      • Obstetrics 13: Assisted Delivery Portal
      • Obstetrics 14: Shoulder Dystocia Portal
      • Obstetrics 15: Third-stage and Postpartum Emergencies Portal
      • Obstetrics 16: Thromboembolic Disease and Pregnancy Portal
    • Section 23
      Pediatrics
      • Pediatrics 1: Physiologic and Anatomic Considerations Portal
      • Pediatrics 2: Tracheal Foreign Body Portal
      • Pediatrics 3: Epiglottitis Portal
      • Pediatrics 4: Laryngotracheal Bronchitis (Croup) Portal
      • Pediatrics 5: Bacterial Tracheitis Portal
      • Pediatrics 6: Bronchiolitis Portal
      • Pediatrics 7: Pneumonia Portal
      • Pediatrics 8: Sepsis Portal
      • Pediatrics 9: Meningitis Portal
      • Pediatrics 10: Diphtheria Portal
      • Pediatrics 11: Glasgow Coma Scale Portal
      • Pediatrics 12: Intraosseous Vascular Access
    • Section 24
      Sedation/
      Pain Control/
      Anesthesia
      • Sedation/Pain Control/Anesthesia 1: Procedural Sedation
      • Sedation/Pain Control/Anesthesia 2: Management of Combative, Agitated, Delirious Patients
      • Sedation/Pain Control/Anesthesia 3: Malignant Hyperthermia Portal
    • Section 25
      Toxicology
      • Toxicology 1: Systematic Approach
      • Toxicology 2: Essential Antidotes Portal
      • Toxicology 3: Acetaminophen Overdose Portal
      • Toxicology 4: Aspirin Overdose Portal
      • Toxicology 5: Tricyclic Antidepressants Overdose Portal
      • Toxicology 6: Beta Blocker Toxicity Portal
      • Toxicology 7: Calcium Channel Blocker Toxicity Portal
      • Toxicology 8: Bendodiazepine Overdose Portal
      • Toxicology 9: Alcohol Withdrawal Portal
      • Toxicology 10: Toxic Alcohols: Methanol and Ethylene Glycol
      • Toxicology 11: Cocaine Ingestion Portal
      • Toxicology 12: Narcotic Overdose Portal
      • Toxicology 13: Amphetamine Analog Intoxication Portal
      • Toxicology 14: Iron Ingestion Portal
      • Toxicology 15: Carbon Monoxide Poisoning Portal
      • Toxicology 16: Hyperbaric Oxygen and Normobaric Oxygen
      • Toxicology 17: Cyanide Poisoning Portal
      • Toxicology 18: Organophosphates Toxicity Portal
    • Section 26
      Trauma Care
      • Trauma Care 1: Shock Portal
      • Trauma Care 2: Shock Evaluation Overview Portal
      • Trauma Care 3: Use of Hemostatic Agents to Control Major Bleeding Portal
      • Trauma Care 4: Severe Traumatic Brain Injury—Adult 
      • Trauma Care 5: Severe Traumatic Brain Injury—Pediatric
      • Trauma Care 6: Compartment Syndrome
    • Section 27
      Tropical Medicine
      • Tropical Medicine 2: Introduction
      • Tropical Medicine 3: Fever and Systemic Manifestations
      • Tropical Medicine 4: Gastrointestinal and Abdominal Manifestations
      • Tropical Medicine 5: Dermatological Manifestations
      • Tropical Medicine 6: Muscular Manifestations (Including Myocardium)
      • Tropical Medicine 7: Neurological Manifestations
      • Tropical Medicine 8: Ocular Manifestations
      • Tropical Medicine 9: Pulmonary Manifestations
      • Tropical Medicine 10: Urogenital Manifestations
      • Tropical Medicine 11: Disorders of Nutrition and Hydration
      • Tropical Medicine 12: Medicine in Austere Environs
      • Tropical Medicine 13: Antiparasitic Primer
      • Tropical Medicine 14: Concise Parasitic Identification
      • Tropical Medicine 15: Bibliography
    • Section 28
      Ultrasound
      • Ultrasound 1: Emergency Ultrasound Applications Portal
      • Ultrasound 2: Emergency Ultrasound Techniques Portal

Print page

Cardiovascular 13: Hypertensive Crises Portal

Incidence/Epidemiology
For reasons that are unclear, hypertensive crises occur in 1% to 2% of cases of untreated essential hypertension.

Risk Factors for Hypertensive Crises

  • African American heritage

  • Use of oral contraceptives

  • Secondary hypertension (renovascular, pheochromocytoma)

  • Sudden withdrawal from alpha 2 stimulants (Clonidine [Catapres])

  • Cigarette smoking

  • Low socioeconomic class

  • Alcohol withdrawal (Non-compliance with treatment)

  • Sudden withdrawal from beta blockers

Definitions: Urgencies vs. Emergencies

Hypertensive emergencies require immediate reduction of BP (not necessarily to normal) to prevent or limit target organ damage. (Examples: hypertensive encephalopathy, intracranial hemorrhage, acute left ventricular failure with pulmonary edema, aortic dissection, eclampsia or severe pregnancy-induced hypertension, unstable angina, and acute MI)

Hypertensive urgencies require lowering BP within 24 hours. (Examples: accelerated or malignant hypertension without symptoms or progressive target-organ complications, severe post-operative hypertension)

  • Absolute BP level is not used to define whether a situation is urgent or emergent. Elevated BP alone, without symptoms or target organ damage, does not require emergency therapy. Rate of rise of BP may be more important than absolute BP level.

Patients in Hypertensive Crisis
History

  • If possible, determine the patient's duration of hypertension, current drug therapy, and history of onset of the present crisis.

  • Is the patient experiencing chest pain, dyspnea, headache, visual changes, loss of consciousness?

  • Is the patient pregnant?

  • Is there a possibility of alcohol or drug intoxication (especially methamphetamine or other stimulant) or withdrawal? See Vol III—Toxicology Portals

Physical examination

  • Focus assessment on target organ damage.

  • Perform a neurological exam to determine change in mental status or any loss of motor or sensory function.

  • Carefully examine the optic fundi for evidence of papilledema, hemorrhage, or evidence of chronic retinopathy of diabetes.

  • Perform cardiac and pulmonary exams looking for signs of CHF.

  • Examine the abdomen and peripheral pulses with attention to symmetry of pulses.

Pertinent diagnostic studies

  • Draw blood samples for CBC, electrolytes, BUN, creatinine, and transaminase; obtain a urinalysis.

  • Order an ECG for all patients.

  • A chest x-ray is also advisable.

  • If there are any abnormal neurologic findings, obtain a head CT to rule out intracranial hemorrhage.

  • Select patients may need thyroid function studies, pheochromocytoma studies, and/or renovascular evaluation (after BP is stabilized).

General treatment principles

  1. In a true emergency, the timing of treatment of the elevated BP is after obtaining the ECG but before the lab and x-ray results are available.

  2. Most patients in hypertensive crises cannot tolerate a rapid BP reduction to normal levels. Many patients develop cerebral hypoperfusion at normal BP levels due to impaired autoregulation in the cerebral circulation. The lower level of cerebral autoregulation is approximately 25% below the resting mean arterial pressure (MAP). Therefore, the goal of treatment in hypertensive crises is to reduce the MAP by 20% to 25% over a period of minutes to hours.

    MAP=diastolic BP + 1/3 (systolic pressure—diastolic pressure)

  3. For all patients in hypertensive crisis, monitor urine output carefully. Most patients in hypertensive crisis are volume depleted, probably from pressure-induced diuresis. Therefore, reserve diuretics and fluid restriction for patients who are clinically fluid-overloaded. In fact, if a patient is severely volume depleted (as evidenced by marked orthostatic fall in BP or prerenal azotemia), an infusion of isotonic saline solution may be needed to improve renal function.

  4. If using intravenous medications to obtain rapid BP reduction, begin oral medications as early as practical to allow for IV therapy discontinuation as soon as possible.

Management of Specific Hypertensive Emergencies

Central Nervous System Conditions or Complications

1. Hypertensive encephalopathy

  1. Symptoms of hypertensive encephalopathy include a severe headache (of somewhat gradual onset and progression), nausea, vomiting, visual changes, and varying degrees of obtundation. Usually the BP is high (> 250/150). There is usually a history of untreated hypertension, inadequately treated hypertension, or discontinuation of antihypertensive medication (often without medical advice.) The symptoms have an insidious onset over 48 to 72 hours.

  2. Other clinical findings may include retinopathy (including papilledema), disorientation, focal neurologic signs, generalized or focal seizures, asymmetric reflexes, and nystagmus.

  3. Hypertensive encephalopathy is a diagnosis of exclusion that requires ruling out stroke, subarachnoid hemorrhage, intracranial mass, seizure disorder, vasculitis, and encephalitis.

  4. The preferred drug for treating hypertensive encephalopathy is sodium nitroprusside. (Labetalol is an alternative.)

  5. The goal of treatment is to reduce BP over 2 to 3 hours by no more than 25% reduction in MAP.

  6. Relief of headache and clearing of the sensorium should accompany BP reduction. If these particular symptoms do not improve, reconsider the diagnosis and examine for concurrent medical problems.

2. Subarachnoid hemorrhage

  1. In contrast to the headache of hypertensive encephalopathy, the headache of subarachnoid hemorrhage is of sudden onset, is very severe, and may be accompanied by nuchal rigidity. Diagnosis may be made from a CT scan of the head or, if the CT is non-diagnostic, by finding bloody CSF from lumbar puncture.

  2. There is no consensus at present regarding the wisdom of attempting BP reduction for these patients. Angiography has demonstrated that there is severe vasospasm around the hemorrhage site. Lowering the BP may increase the area of ischemia and lead to cerebral infarction.

  3. Reduce severe hypertension gradually over 6 to 12 hours by 20% to 25% of the MAP using sodium nitroprusside. (However, reduce no lower than about 180/100.) If BP reduction worsens the clinical status of the patient, discontinue the infusion. The BP should return to pretreatment values in 2 to 4 minutes. Do not use long-acting agents; inadvertent hypotension may be disastrous.

  4. If the patient has signs of increased ICP (either on CT scan or clinically), treat the patient with mannitol, dexamethasone, hyperventilation, or surgery.

3.   Intraparenchymal intracranial hemorrhage

  1. Again, there is no consensus regarding when to treat BP elevations in patients. Cerebral edema may cause an increase in ICP, which results in a requirement for a higher MAP in order to perfuse the brain adequately.

  2. No treatment is recommended if the BP is < 180/105.

  3. If the BP range has been from 180/105 to 230/120 persistently for over 1 hour, initiate treatment with oral labetalol, nifedipine, or captopril. Labetalol may also be given IV if the patient cannot take medications by mouth.

  4. If the BP is > 230/120 for more than 20 minutes, use labetalol 20 mg IV every 10 to 20 minutes as needed.

  5. If the diastolic BP is > 140, use a sodium nitroprusside infusion. If the patient's neurologic deficit or mental status worsens, the infusion may be decreased or discontinued.

4.   Acute ischemic stroke1

Treatment guidelines for hypertension in the setting of acute ischemic stroke differ depending on the patient’s eligibility for fibrinolytic treatment. (See Vol III—NEU2 Treatment of Stroke)

For patients not eligible for fibrinoytics or for whom fibrinolytic therapy is not the selected management strategy:

  • For patients with systolic BP >220 and/or diastolic BP >120, regardless of symptoms, the goal is to lower BP 15% to 25% over 24 hours.
  • For patients with BP in the hypertensive range but <220 systolic BP and/or <120 diastolic BP, withhold treatment if the patient is asymptomatic. If end-stage organ involvement (myocardial infarction, pulmonary edema, or encephalopathy) is present, treat to lower BP 15% to 20% over 24 hours or as dictated by the patient's clinical condition.

For stroke patients for whom fibrinolytic therapy is planned:

  • For patients with systolic BP >185 and/or diastolic BP >110, reduce BP below these levels in order to administer fibrinolytics. This must take place in the 3-hour window between symptom onset and planned fibrinolytic administration.

For all these scenarios, a variety of agents may be used including labetalol, nicardipine, nitroglycerin intravenous, and sodium nitroprusside. For doses, see the table Drugs Used to Treat Hypertensive Crisis, at the end of this portal.

Cardiac Complications

1. Acute left ventricular failure (See Vol III—CV 12, Acute Heart Failure.)

  1. For patients with acute left ventricular failure due to uncontrolled hypertension, lower the BP immediately to decrease the workload on the left ventricle.

  2. Agents useful for BP control in this setting include intravenous nitroglycerin, sodium nitroprusside, and ACE inhibitors, such as intravenous enalapril [enalaprilat]. For doses, see the table Drugs Used to Treat Hypertensive Crisis, at the end of this portal. If fluid overload is suspected, give furosemide 40 to 80 mg IV.

  3. Start an oral ACE inhibitor (such as captopril or enalapril) so that IV drug therapy may be discontinued as soon as possible.

2. Unstable angina and/or MI

The preferred antihypertensive drug is nitroglycerin IV. Remember however that the BP reduction is ancillary to measures to improve or restore coronary patency with heparin, fibrinolytics, angioplasty, or surgery.

3.  Thoracic aortic dissection

  1. Symptoms of thoracic aortic dissection include sudden onset of severe pain in the chest, back, or abdomen. The pain is persistent and may migrate downward as the dissection extends. The pain is often described as ripping or tearing.

  2. Physical findings may include discrepancies between pulses, a murmur of aortic insufficiency, and neurologic deficits. A chest x-ray, which shows mediastinal widening, may suggest the diagnosis. Echocardiography or CT scanning may be helpful in confirming the presence of a dissection.

  3. If the dissection involves the aortic arch, in conjunction with efforts to lower the BP, emergent surgery is the preferred treatment.

  4. If the dissection is distal to the left subclavian artery, antihypertensive drugs are the preferred treatment. In aortic dissection, the treatment goal is to reduce the BP rapidly (within 15 to 30 minutes) to a systolic pressure of 100 to 120 or a MAP of less than or equal to 80 mm Hg.

  5. Use labetolol 20 to 80 mg as IV bolus every 5 to 10 minutes.

  6. Alternatively, pretreat the patient (initially) with a beta blocker, reserpine, or methyldopa (to decrease reflex adrenergic stimulation from vasodilators). Next, use sodium nitroprusside to rapidly lower BP to the desired range.
    Diazoxide and hydralazine are contraindicated in aortic dissection.

  7. After initiating treatment and instituting appropriate monitoring (in an intensive care unit), transfer the patient to the angiography suite to confirm the diagnosis and to locate the site and extent of the dissection

Hypercatecholaminemia States

These hypertensive conditions (which include pheochromocytoma, MAO inhibitor interactions, clonidine withdrawal syndrome, and cocaine ingestion) are usually handled as hypertensive urgencies and can be treated with oral medications. The appropriate treatment may consist of prazosin (Minipress), resumption of clonidine (Catapres), or nifedipine (Procardia and other) PO.

Preeclampsia/Eclampsia: (Vol III—OB8 Hypertension in Pregnancy)

Summary of Treatment Time Frames for Hypertensive Emergencies

Clinical Setting

Time Goal to Achieve
Target BP Reduction

Aortic dissection
Pulmonary edema

15 to 30 minutes

Hypertensive encephalopathy

2 to 3 hours

Acute cerebral infarction
Intracranial hemorrhage
(decrease no lower than 170 to 180/100)

6 to 12 hours


Drugs Used to Treat Hypertensive Crises

Parenteral Vasodilators

Drug Cautions Dose Onset Cautions
Sodium nitroprusside  0.25 to 10 µg/kg/min
as IV infusion; maximal dose for 10 minutes only
Instantaneous Nausea, vomiting, muscle twitching; prolonged use may cause thiocyanate intoxication, methemoglobinemia, cyanide poisoning
Nitroglycerin 5 to 100 µg/min as IV infusion 2 to 5 minutes Headache, flushing, tachycardia, vomiting, methemoglobinemia
Diazoxide  
(Hyperstat)
1 to 3 mg/kg IV bolus one 15 to 30 sec, repeat q 5 to 15 minutes until desired effect, or 15 to 30 mg/min by IV infusion 1 to 2 minutes Hypotension, N/V tachycardia,
aggravation of angina, hyperglycemia
Hydralazine
(Apresoline)
10 to 20 mg as IV bolus; may repeat in 30 minutes 10 minutes Tachycardia, headache, vomiting, aggravation of angina
Enalapril
(Enalaprilat [Vasotec])
0.625 to 1.25 mg IV
every 6 h
15 to 60 minutes Renal failure in patients with bilateral renal artery stenosis; hypotension

Parenteral Adrenergic Inhibitors

Drug Cautions Dose Onset Cautions
Phentolamine
(Regitine)
5 to 15 mg as IV bolus 1 to 2 minutes Tachycardia, orthostatic hypotension
Labetalol
(Trandate, Normodyne)
20 to 80 mg as IV bolus every 10 minutes
2 mg/min as IV infusion
5 to 10 minutes Bronchoconstriction,
heart block, orthostatic hypotension
Methyldopa
(Aldomet)
250 to 500 mg as
IV infusion every 6 h
30 to 60 minutes Drowsiness

Oral Agents

Drug Cautions Dose Onset Cautions
Captopril
(Capoten)
25 mg PO; repeat prn 15 to 30 minutes Hypotension, renal failure in bilateral artery stenosis
 Clonidine
(Catapres)
0.1 to 0.2 mg PO; repeat every hour prn to total dose of 0.6 mg 30 to 60 minutes Hypotension, dry mouth, drowsiness
Labetalol
(Trandate, Normodyne)
200 to 400 mg PO;
repeat every 2 to 3 h
30 min
to 2 h
Bronchoconstriction, heart block, orthostatic hypotension

Reference

  1. Hazinski MF, Samson R, Schexnayder S, eds. 2010 Handbook of Emergency Cardiovascular Care. Dallas, TX: American Heart Association; 2010:21.

Edition 13-October 2011

Copyright©CALS. Comprehensive Advanced Life Support | © 2012 CALS Program